Displaying 500 actively recruiting clinical trials nationwide

Study Name Sponsor Status Trial Phase Quota Distance
Efficacy of CROWN in Repair and Maintenance of the Intestinal Mucosa in Patients With CD Receiving Anti-TNF Therapy Prometheus Laboratories Recruiting
2
Trial Phase
240
Trial Size
2.25 2 miles
Phase 2b Study to Evaluate the Efficacy and Safety of GBR 830 in Adults With Moderate to Severe Atopic Dermatitis Glenmark Pharmaceuticals S.A. Recruiting
2
Trial Phase
392
Trial Size
2.25 2 miles
Veliparib and Atezolizumab Either Alone or in Combination in Treating Patients With Stage III-IV Triple Negative Breast Cancer National Cancer Institute (NCI) Recruiting
2
Trial Phase
90
Trial Size
3.14 3 miles
A Study of Multiple Immunotherapy-Based Treatment Combinations in Hormone Receptor (HR)-Positive Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer Hoffmann-La Roche Recruiting
1
Trial Phase
111
Trial Size
3.14 3 miles
Aspirin in Preventing Recurrence of Cancer in Patients With Node Positive HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy Alliance for Clinical Trials in Oncology Recruiting
3
Trial Phase
2936
Trial Size
3.14 3 miles
A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis Eli Lilly and Company Recruiting
3
Trial Phase
750
Trial Size
3.14 3 miles
Safety and Efficacy Study of Filgotinib, GS-9876 and Tirabrutinib in Adults With Active Sjogren's Syndrome Gilead Sciences Recruiting
2
Trial Phase
140
Trial Size
3.14 3 miles
An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus Genentech, Inc. Recruiting
2
Trial Phase
240
Trial Size
3.14 3 miles
Multiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's Disease Proclara Biosciences, Inc. Recruiting
1
Trial Phase
66
Trial Size
3.50 4 miles
Nativis Voyager for Newly Diagnosed GBM Nativis, Inc. Recruiting N/A
10
Trial Size
3.50 4 miles
Study to Assess the Safety and Efficacy of ONZETRA® Xsail® (Sumatriptan Nasal Powder) for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents Avanir Pharmaceuticals Recruiting
3
Trial Phase
420
Trial Size
3.50 4 miles
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo Shire Recruiting
3
Trial Phase
930
Trial Size
3.50 4 miles
Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo Shire Recruiting
3
Trial Phase
721
Trial Size
3.50 4 miles
A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With Fibromyalgia Astellas Pharma Inc Recruiting
2
Trial Phase
178
Trial Size
3.50 4 miles
RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty Boston Scientific Corporation Recruiting
3
Trial Phase
396
Trial Size
4.30 4 miles
Bridging Community Gaps Photovoice Boston University Charles River Campus Recruiting N/A
180
Trial Size
4.37 4 miles
A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD) Hoffmann-La Roche Recruiting
3
Trial Phase
750
Trial Size
9.92 10 miles
Clostridium Difficile Vaccine Efficacy Trial Pfizer Recruiting
3
Trial Phase
15776
Trial Size
10.08 10 miles
Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Adults Medicago Recruiting
3
Trial Phase
10000
Trial Size
10.08 10 miles
A Pancreatic Cancer Screening Study in Individuals With New-Onset Diabetes Mellitus Western Connecticut Health Network Recruiting N/A
800
Trial Size
11.54 12 miles
"Efficacy of Botulinum Toxin Injection in Reducing Limb Pain in Patients With Complex Regional Pain Syndrome" VA Connecticut Healthcare System Recruiting
1
Trial Phase
20
Trial Size
12.85 13 miles
Development of the ERA-Microbiome Non-invasive Diagnosis Tool Igenomix Recruiting N/A
210
Trial Size
13.59 14 miles
Revolution™ Peripheral Atherectomy System for Lower Extremity Peripheral Arterial Revascularization Rex Medical Recruiting N/A
121
Trial Size
15.44 15 miles
Cognitive Remediation Therapy (CRT) for Adults Treated for Cancer Yale University Recruiting N/A
30
Trial Size
15.46 15 miles
Sharing and Talking About my Preferences VA Connecticut Healthcare System Recruiting N/A
484
Trial Size
15.46 15 miles
Postprandial Liver and Spleen Stiffness Measurements in the Noninvasive Diagnosis of Cirrhosis VA Connecticut Healthcare System Recruiting N/A
19
Trial Size
15.46 15 miles
Effects of Psilocybin in Post-Traumatic Headache Yale University Recruiting
2
Trial Phase
24
Trial Size
15.46 15 miles
A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s) Janssen Research & Development, LLC Recruiting
3
Trial Phase
360
Trial Size
15.89 16 miles
A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease ACADIA Pharmaceuticals Inc. Recruiting
2
Trial Phase
432
Trial Size
15.89 16 miles
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Boehringer Ingelheim Recruiting
3
Trial Phase
600
Trial Size
15.89 16 miles
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency Luitpold Pharmaceuticals Recruiting
3
Trial Phase
3014
Trial Size
15.89 16 miles
Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP Boston Scientific Corporation Recruiting N/A
2600
Trial Size
15.89 16 miles
Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis ACADIA Pharmaceuticals Inc. Recruiting
3
Trial Phase
356
Trial Size
15.89 16 miles
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Hoffmann-La Roche Recruiting
3
Trial Phase
1300
Trial Size
15.89 16 miles
A Study of INCB018424 Phosphate Cream in Subjects With Vitiligo Incyte Corporation Recruiting
2
Trial Phase
150
Trial Size
15.89 16 miles
A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Janssen Research & Development, LLC Recruiting
3
Trial Phase
684
Trial Size
15.89 16 miles
Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry Boston Scientific Corporation Recruiting N/A
2000
Trial Size
15.89 16 miles
A Phase 3 Study to Evaluate ADX-102 Ophthalmic Solution in Subjects With Non-infectious Anterior-uveitis. Aldeyra Therapeutics, Inc. Recruiting
3
Trial Phase
100
Trial Size
15.89 16 miles
Palbociclib in Real World Practice Pfizer Recruiting N/A
1500
Trial Size
15.89 16 miles
Safety and Efficacy of Adjunctive Pimavanserin in Adults With Parkinson's Disease and Inadequately Controlled Depression ACADIA Pharmaceuticals Inc. Recruiting
2
Trial Phase
65
Trial Size
15.89 16 miles
Phase 3 Efficacy Study of AGN-190584 in Participants With Presbyopia Allergan Recruiting
3
Trial Phase
300
Trial Size
15.89 16 miles
Safety and Efficacy of Oral TXA in Reducing Blood Loss and Transfusion in Hip Fractures Yale University Recruiting
4
Trial Phase
100
Trial Size
16.59 17 miles
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma Bristol-Myers Squibb Available N/A
0
Trial Size
17.18 17 miles
Patient Driven Recovery With Nalmefene and Coaching Yale University Recruiting
2
Trial Phase
30
Trial Size
17.18 17 miles
Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps Sanofi Recruiting
3
Trial Phase
360
Trial Size
17.18 17 miles
A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate Cancer MedImmune LLC Recruiting
1
Trial Phase
224
Trial Size
17.18 17 miles
Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine Tian Medical Inc. Recruiting
3
Trial Phase
180
Trial Size
17.18 17 miles
A Phase Ib Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Avelumab in Combination With M9241(NHS-IL12) EMD Serono Recruiting
1
Trial Phase
170
Trial Size
17.18 17 miles
A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE Ampel BioSolutions, LLC Recruiting
4
Trial Phase
62
Trial Size
17.18 17 miles
Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata Concert Pharmaceuticals Recruiting
2
Trial Phase
90
Trial Size
17.18 17 miles
Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata Pfizer Recruiting
2
Trial Phase
132
Trial Size
17.18 17 miles
Neuroendocrine Response to Oral Alcohol Administration Yale University Recruiting
1
Trial Phase
85
Trial Size
17.18 17 miles
Safety Evaluation of Repeat Placement of the S8 Sinus Implant in Chronic Sinusitis Patients With Nasal Polyps (ENCORE) Intersect ENT Recruiting
3
Trial Phase
50
Trial Size
17.18 17 miles
Imaging mGluR5 and Synaptic Density in Psychiatric Disorders Yale University Recruiting N/A
90
Trial Size
17.18 17 miles
Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita Palvella Therapeutics, Inc. Recruiting
2
Trial Phase
60
Trial Size
17.18 17 miles
The Role of Neuroactive Steroids in Stress, Drug Craving and Drug Use in Cocaine Use Disorders Yale University Recruiting
1
Trial Phase
60
Trial Size
17.18 17 miles
A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH) Teva Pharmaceutical Industries Recruiting
3
Trial Phase
300
Trial Size
17.73 18 miles
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug AbbVie Recruiting
3
Trial Phase
1640
Trial Size
17.73 18 miles
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia Eli Lilly and Company Recruiting
2
Trial Phase
380
Trial Size
17.73 18 miles
Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS) Hoffmann-La Roche Recruiting
3
Trial Phase
600
Trial Size
17.73 18 miles
A Study Comparing the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Chronic Cluster Headache (CCH) Teva Pharmaceutical Industries Recruiting
3
Trial Phase
300
Trial Size
17.73 18 miles
Lyme Test Indication Combinations (LyTIC) Study Oxford Immunotec Recruiting N/A
500
Trial Size
17.73 18 miles
A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease Eli Lilly and Company Recruiting
2
Trial Phase
285
Trial Size
17.73 18 miles
Mindfulness Based Stress Reduction for Metabolic Syndrome Yale University Recruiting N/A
40
Trial Size
17.88 18 miles
First In Human, Single Escalating Oral Dose Study Of PF-06882961 In Healthy Adult Subjects Pfizer Recruiting
1
Trial Phase
24
Trial Size
17.88 18 miles
Study of MK-7684 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors (MK-7684-001) Merck Sharp & Dohme Corp. Recruiting
1
Trial Phase
240
Trial Size
17.88 18 miles
A Study of RO7198457 (Personalized Cancer Vaccine [PCV]) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors Genentech, Inc. Recruiting
1
Trial Phase
572
Trial Size
17.88 18 miles
Yale College Project Randomized Control Trial Yale University Recruiting N/A
200
Trial Size
17.88 18 miles
A Study To Assess The Safety, Tolerability, And Pharmacokinetics (PK) Of Multiple Doses Of PF-06865571 In Healthy, Including Overweight And Obese, Adult Subjects Pfizer Recruiting
1
Trial Phase
70
Trial Size
17.88 18 miles
Electronic Cigarette Use in Young Adult Men and Women Yale University Recruiting N/A
30
Trial Size
17.88 18 miles
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids Bayer Recruiting
3
Trial Phase
1050
Trial Size
17.88 18 miles
A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder, in Adults at Imminent Risk for Suicide Janssen Research & Development, LLC Recruiting
3
Trial Phase
224
Trial Size
17.88 18 miles
This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer. Boehringer Ingelheim Recruiting
1
Trial Phase
90
Trial Size
17.88 18 miles
A Phase I Study of BTRC4017A in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers Genentech, Inc. Recruiting
1
Trial Phase
449
Trial Size
17.88 18 miles
Galantamine and CBT4CBT Pilot Yale University Recruiting
1
Trial Phase
30
Trial Size
17.88 18 miles
Study To Assess Local Tolerability of Crisaborole 2% Ointment and Vehicle Ointment In Healthy Participants Using Subject-reported Assessments and Objective Measurements Pfizer Recruiting
1
Trial Phase
32
Trial Size
17.88 18 miles
Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer Taiho Oncology, Inc. Available N/A
0
Trial Size
17.91 18 miles
Olaparib With or Without Cediranib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer National Cancer Institute (NCI) Recruiting
2
Trial Phase
90
Trial Size
17.91 18 miles
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors CytomX Therapeutics Recruiting
1
Trial Phase
150
Trial Size
17.91 18 miles
Feasibility Study on LITT for Medical Refractory Epilepsy Monteris Medical Recruiting N/A
45
Trial Size
17.91 18 miles
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer Hoffmann-La Roche Recruiting
3
Trial Phase
850
Trial Size
17.91 18 miles
A Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor Sera Prognostics, Inc. Recruiting N/A
4000
Trial Size
17.91 18 miles
Impact of Fever Prevention in Brain Injured Patients C. R. Bard Recruiting N/A
1176
Trial Size
17.91 18 miles
A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL) Bristol-Myers Squibb Recruiting
2
Trial Phase
65
Trial Size
17.91 18 miles
CD40 Agonistic Antibody APX005M in Combination With Nivolumab Apexigen, Inc. Recruiting
1
Trial Phase
99
Trial Size
17.91 18 miles
A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Stage IB, II, or IIIA Resectable and Untreated Non-Small Cell Lung Cancer (NSCLC) Genentech, Inc. Recruiting
2
Trial Phase
180
Trial Size
17.91 18 miles
A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously Treated Solid Tumors and Hematologic Malignancies AbbVie Recruiting
1
Trial Phase
92
Trial Size
17.91 18 miles
A Study to Test Combination Treatments in Patients With Advanced Gastric Cancer Bristol-Myers Squibb Recruiting
2
Trial Phase
300
Trial Size
17.91 18 miles
A Study to Evaluate Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection, With APRI (a Predictor of Hepatic Fibrosis) ≤ 1, and Have Never Received HCV Treatment AbbVie Recruiting
3
Trial Phase
230
Trial Size
17.91 18 miles
Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis Ra Pharmaceuticals Recruiting
2
Trial Phase
36
Trial Size
17.91 18 miles
Entinostat and Pembrolizumab in Treating Patients With Myelodysplastic Syndrome After DNMTi Therapy Failure National Cancer Institute (NCI) Recruiting
1
Trial Phase
27
Trial Size
17.91 18 miles
Tesevatinib in Subjects With ADPKD Kadmon Corporation, LLC Recruiting
2
Trial Phase
100
Trial Size
17.91 18 miles
Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients Bristol-Myers Squibb Recruiting
3
Trial Phase
600
Trial Size
17.91 18 miles
A Study of ALX148 in Patients With Advanced Solid Tumors and Lymphoma Alexo Therapeutics, Inc. Recruiting
1
Trial Phase
142
Trial Size
17.91 18 miles
Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial Tandem Diabetes Care, Inc. Recruiting N/A
90
Trial Size
17.91 18 miles
Genomic Basis of Neurodevelopmental and Brain Outcomes in Congenital Heart Disease (CHD Brain and Genes) Children's Hospital Medical Center, Cincinnati Recruiting N/A
400
Trial Size
17.91 18 miles
Registry Evaluating Premature and Term-Near-Term Neonates With Pulmonary Hypertension Receiving Inhaled Nitric Oxide Mallinckrodt Recruiting N/A
168
Trial Size
17.91 18 miles
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer National Cancer Institute (NCI) Recruiting
2
Trial Phase
180
Trial Size
17.91 18 miles
A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma Bristol-Myers Squibb Recruiting
2
Trial Phase
200
Trial Size
17.91 18 miles
Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Bristol-Myers Squibb Recruiting
2
Trial Phase
400
Trial Size
17.91 18 miles
Safety and Pharmacokinetics (PK) of Escalating Doses of MTIG7192A as a Single Agent and in Combination With Atezolizumab in Locally Advanced or Metastatic Tumors Genentech, Inc. Recruiting
1
Trial Phase
300
Trial Size
17.91 18 miles
Registry of Patients Treated With Systemic Mold-Active Triazoles Astellas Pharma Inc Recruiting N/A
2000
Trial Size
17.91 18 miles
Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases National Cancer Institute (NCI) Recruiting
2
Trial Phase
98
Trial Size
17.91 18 miles
A Study Evaluating the Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Vertex Pharmaceuticals Incorporated Recruiting
2
Trial Phase
105
Trial Size
17.91 18 miles
An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC) Bristol-Myers Squibb Recruiting
2
Trial Phase
100
Trial Size
17.91 18 miles
Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial Yale University Recruiting
2
Trial Phase
100
Trial Size
17.91 18 miles
A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus Celgene Recruiting
2
Trial Phase
280
Trial Size
17.91 18 miles
Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations National Cancer Institute (NCI) Recruiting
2
Trial Phase
209
Trial Size
17.91 18 miles
PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease Sino Medical Sciences Technology Inc. Recruiting N/A
1632
Trial Size
17.91 18 miles
Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer NRG Oncology Recruiting N/A
282
Trial Size
17.91 18 miles
A Study of Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma [IMbrave150] Hoffmann-La Roche Recruiting
3
Trial Phase
480
Trial Size
17.91 18 miles
Human Epilepsy Project 2: Resistant Focal Seizures Study Epilepsy Foundation of America Recruiting N/A
205
Trial Size
17.91 18 miles
Patient and Parent Preferences for an On-Body Automated Insulin Delivery System Joslin Diabetes Center Recruiting N/A
200
Trial Size
17.91 18 miles
Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors Johns Hopkins University Recruiting N/A
1000
Trial Size
17.91 18 miles
The Effect of Glucagon on Rates of Hepatic Mitochondrial Oxidation in Man Assessed by PINTA Yale University Recruiting
1
Trial Phase
12
Trial Size
17.91 18 miles
A Study of Atezolizumab as Adjuvant Therapy in Participants With Renal Cell Carcinoma (RCC) at High Risk of Developing Metastasis Following Nephrectomy Hoffmann-La Roche Recruiting
3
Trial Phase
664
Trial Size
18.06 18 miles
A Study to Evaluate Safety, Efficacy, and Tolerability of TEZ/IVA in Orkambi® (Lumacaftor/Ivacaftor) -Experienced Subjects With Cystic Fibrosis (CF) Vertex Pharmaceuticals Incorporated Recruiting
3
Trial Phase
90
Trial Size
18.06 18 miles
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III) Shockwave Medical, Inc. Recruiting N/A
334
Trial Size
18.06 18 miles
A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting UCB Pharma Recruiting
2
Trial Phase
60
Trial Size
18.06 18 miles
A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of GZ/SAR402671 in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene Mutation Sanofi Recruiting
2
Trial Phase
243
Trial Size
18.06 18 miles
First-in-Human Study of MS201408-0005A as Single Agent and in Combinations EMD Serono Recruiting
1
Trial Phase
60
Trial Size
18.06 18 miles
Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer ARMO BioSciences Recruiting
3
Trial Phase
566
Trial Size
18.06 18 miles
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma Hoffmann-La Roche Recruiting
2
Trial Phase
500
Trial Size
18.06 18 miles
Ipilimumab and Nivolumab in Patients With Anti-PD-1-axis Therapy-resistant Advanced Non-small Cell Lung Cancer. Yale University Recruiting
2
Trial Phase
50
Trial Size
18.06 18 miles
A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma Yale University Recruiting
2
Trial Phase
25
Trial Size
18.06 18 miles
Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of BMS-986089 in Ambulatory Boys With Duchenne Muscular Dystrophy Hoffmann-La Roche Recruiting
2
Trial Phase
159
Trial Size
18.06 18 miles
A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps Hoffmann-La Roche Recruiting
3
Trial Phase
120
Trial Size
18.06 18 miles
The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study Medtronic Cardiovascular Recruiting N/A
40
Trial Size
18.06 18 miles
REDUCE LAP-HF TRIAL II Corvia Medical Recruiting N/A
380
Trial Size
18.06 18 miles
A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen Hoffmann-La Roche Recruiting
3
Trial Phase
730
Trial Size
18.06 18 miles
Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma RElief Brigham and Women's Hospital Recruiting
4
Trial Phase
1200
Trial Size
18.06 18 miles
Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage Edge Therapeutics Inc Recruiting
3
Trial Phase
374
Trial Size
18.06 18 miles
SPECT/CT Imaging of Skeletal Muscle Perfusion Yale University Recruiting N/A
50
Trial Size
18.06 18 miles
A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma Eli Lilly and Company Recruiting
2
Trial Phase
231
Trial Size
18.06 18 miles
Assessment of the Biodistribution and Safety of [18F]MNI-968 in Healthy Subjects Molecular NeuroImaging Recruiting
1
Trial Phase
6
Trial Size
18.06 18 miles
Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer Yale University Recruiting
2
Trial Phase
25
Trial Size
18.06 18 miles
Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab Yale University Recruiting
2
Trial Phase
88
Trial Size
18.06 18 miles
Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer Array BioPharma Recruiting
3
Trial Phase
645
Trial Size
18.06 18 miles
Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androgen Pathway Inhibitor Hoffmann-La Roche Recruiting
1
Trial Phase
45
Trial Size
18.06 18 miles
Sugammadex and Decreased Time to Extubation Yale University Recruiting
4
Trial Phase
110
Trial Size
18.06 18 miles
Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412) Merck Sharp & Dohme Corp. Recruiting
3
Trial Phase
780
Trial Size
18.06 18 miles
A Study to Evaluate the Efficacy of RO7046015 in Participants With Early Parkinson's Disease Hoffmann-La Roche Recruiting
2
Trial Phase
300
Trial Size
18.06 18 miles
Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors Bayer Recruiting
1
Trial Phase
348
Trial Size
18.06 18 miles
Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis Gilead Sciences Recruiting
3
Trial Phase
800
Trial Size
18.06 18 miles
Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) Gilead Sciences Recruiting
3
Trial Phase
800
Trial Size
18.06 18 miles
Gain-framed Messages and NRT for Lung Cancer Screening Patients Medical University of South Carolina Recruiting N/A
616
Trial Size
18.06 18 miles
Phase 1 Test-retest Evaluation of [18F]MK-6240 PET as an Imaging Marker for Neurofibrillary Tangles in the Brain Molecular NeuroImaging Recruiting
1
Trial Phase
15
Trial Size
18.06 18 miles
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants Janssen Research & Development, LLC Recruiting
1
Trial Phase
6
Trial Size
18.06 18 miles
Post-Market Surveillance With a Novel mHealth Platform Yale University Recruiting N/A
60
Trial Size
18.06 18 miles
Assessment of the Biodistribution and Safety of [18F]MNI-958 in Healthy Subjects Invicro Recruiting
1
Trial Phase
6
Trial Size
18.06 18 miles
A Pilot Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes Yale University Recruiting
1
Trial Phase
15
Trial Size
18.06 18 miles
GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors Genmab Recruiting
1
Trial Phase
188
Trial Size
18.06 18 miles
Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease Otonomy, Inc. Recruiting
3
Trial Phase
160
Trial Size
18.06 18 miles
Bariatric Scalable Internet Treatments Yale University Recruiting N/A
52
Trial Size
18.06 18 miles
Validating Imaging Biomarkers of Small Vessel Disease in Diabetic Individuals Using Advanced MRI Techniques. Yale University Recruiting N/A
50
Trial Size
18.06 18 miles
Comparing an Inexpensive Handheld Ultrasound Machine and a Large Mobile Ultrasound System Yale University Recruiting N/A
75
Trial Size
18.06 18 miles
Immunologic Mechanisms in Neurological Diseases Yale University Recruiting N/A
800
Trial Size
18.06 18 miles
The Use Of Domperidone For The Relief Of Refractory Upper Gastrointestinal GI Symptoms Yale University Recruiting
1
Trial Phase
40
Trial Size
18.06 18 miles
Safety and Efficacy of KY1044 and Atezolizumab in Advanced Cancer Kymab Limited Recruiting
1
Trial Phase
412
Trial Size
18.06 18 miles
A Phase 1 Clinical Trial of ARV-110 in Patients With Metastatic Castration-resistant Prostate Cancer. Arvinas Inc Recruiting
1
Trial Phase
36
Trial Size
18.06 18 miles
Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Acute Treatment Yale University Recruiting
3
Trial Phase
180
Trial Size
18.06 18 miles
Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Maintenance Treatment Yale University Recruiting
3
Trial Phase
80
Trial Size
18.06 18 miles
Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders Yale University Recruiting
2
Trial Phase
40
Trial Size
18.06 18 miles
SV2 PET Imaging With [11C]APP311 Yale University Recruiting N/A
120
Trial Size
18.06 18 miles
Pilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception Femasys Inc. Recruiting N/A
50
Trial Size
18.79 19 miles
Stamford Group Family Nurture Intervention Columbia University Recruiting N/A
160
Trial Size
18.90 19 miles
Children's Learning Centers Group FNI Columbia University Recruiting N/A
280
Trial Size
18.90 19 miles
Expanded Access Program With Nivolumab to Treat Melanoma Bristol-Myers Squibb Available N/A
0
Trial Size
21.01 21 miles
Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy Pfizer Available
4
Trial Phase
0
Trial Size
21.01 21 miles
Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) Pfizer Recruiting
3
Trial Phase
304
Trial Size
21.01 21 miles
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing Inivata Recruiting N/A
530
Trial Size
21.01 21 miles
Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Ipsen Recruiting N/A
100
Trial Size
21.01 21 miles
Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors Ipsen Recruiting N/A
100
Trial Size
21.01 21 miles
A Study to Evaluate Dara-CyBorD in Previously Untreated and Relapsed Subjects With Multiple Myeloma Janssen Scientific Affairs, LLC Recruiting
2
Trial Phase
100
Trial Size
21.01 21 miles
A Study of Melflufen-dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide Oncopeptides AB Recruiting
3
Trial Phase
450
Trial Size
21.01 21 miles
Phase 2 Study of Poziotinib in Patients With NSCLC With EGFR or HER2 Exon 20 Insertion Mutation Spectrum Pharmaceuticals, Inc Recruiting
2
Trial Phase
174
Trial Size
21.01 21 miles
Safety, Tolerability, PK and Antitumor Activity of KPG-121 Plus Enzalutamide in mCRPC Patients Kangpu Biopharmaceuticals, Ltd. Recruiting
1
Trial Phase
24
Trial Size
21.01 21 miles
Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology Stony Brook University Recruiting
4
Trial Phase
144
Trial Size
21.01 21 miles
Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Metastatic TNBC and Tesetaxel Monotherapy in Patients With HER2 Negative MBC Odonate Therapeutics, Inc. Recruiting
2
Trial Phase
130
Trial Size
21.01 21 miles
A Multicenter, 2 Part Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Rheumatoid Arthritis Mallinckrodt Recruiting
4
Trial Phase
232
Trial Size
22.53 23 miles
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO Clearside Biomedical, Inc. Recruiting
3
Trial Phase
460
Trial Size
22.53 23 miles
A Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis AbbVie Recruiting
2
Trial Phase
1055
Trial Size
22.53 23 miles
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) Adare Pharmaceuticals, Inc. Recruiting
2
Trial Phase
100
Trial Size
22.53 23 miles
Fecal Microbiota Transplant National Registry American Gastroenterological Association Recruiting N/A
4000
Trial Size
22.53 23 miles
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy AbbVie Recruiting
3
Trial Phase
855
Trial Size
22.53 23 miles
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy AbbVie Recruiting
3
Trial Phase
300
Trial Size
22.53 23 miles
A Study in Subjects With Moderate Atopic Dermatitis Ralexar Therapeutics, Inc. Recruiting
2
Trial Phase
203
Trial Size
22.55 23 miles
A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors Medical University of South Carolina Recruiting N/A
184
Trial Size
22.55 23 miles
A Study to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea Foamix Ltd. Recruiting
3
Trial Phase
1500
Trial Size
22.55 23 miles
A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris Foamix Ltd. Recruiting
3
Trial Phase
1500
Trial Size
22.55 23 miles
Evaluating the Infectivity, Safety, and Immunogenicity of the Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
1
Trial Phase
80
Trial Size
22.68 23 miles
A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide Janssen Research & Development, LLC Recruiting
3
Trial Phase
224
Trial Size
22.68 23 miles
Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (SYMPATICO) Pharmacyclics LLC. Recruiting
3
Trial Phase
287
Trial Size
22.68 23 miles
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS Alliance Foundation Trials, LLC. Recruiting N/A
1200
Trial Size
22.68 23 miles
Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid Leukemia Astex Pharmaceuticals Recruiting
3
Trial Phase
404
Trial Size
22.68 23 miles
A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) AbbVie Recruiting
3
Trial Phase
740
Trial Size
22.68 23 miles
A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy Stony Brook University Recruiting
4
Trial Phase
412
Trial Size
22.68 23 miles
GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease Incyte Corporation Recruiting
3
Trial Phase
436
Trial Size
22.68 23 miles
Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs Astex Pharmaceuticals Recruiting
3
Trial Phase
408
Trial Size
22.68 23 miles
Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery Stony Brook University Recruiting
4
Trial Phase
80
Trial Size
22.68 23 miles
Fecal Microbial Transplantation for C. Difficile and/or Ulcerative Colitis or Indeterminate Colitis Stony Brook University Recruiting
1
Trial Phase
50
Trial Size
22.68 23 miles
A Registry for Patients Taking Uptravi Actelion Recruiting N/A
500
Trial Size
22.68 23 miles
Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100) Pfizer Recruiting
3
Trial Phase
640
Trial Size
22.68 23 miles
Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) MedDay Pharmaceuticals SA Recruiting
3
Trial Phase
600
Trial Size
22.68 23 miles
A Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Techniques Plus Sylys® Surgical Sealant Cohera Medical, Inc. Recruiting N/A
730
Trial Size
22.68 23 miles
Study of ME-401 in Subjects With Relapsed/Refractory CLL/SLL or FL MEI Pharma, Inc. Recruiting
1
Trial Phase
84
Trial Size
22.68 23 miles
A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001) Merck Sharp & Dohme Corp. Recruiting
3
Trial Phase
4872
Trial Size
22.68 23 miles
A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Reduced Ejection Fraction Bayer Recruiting
2
Trial Phase
384
Trial Size
22.68 23 miles
A Safety and Efficacy Study of Pracinostat and Azacitidine in Patients With High Risk Myelodysplastic Syndromes Helsinn Healthcare SA Recruiting
2
Trial Phase
120
Trial Size
22.68 23 miles
Quality of Recovery After Reversal With Neostigmine or Sugammadex. Stony Brook University Recruiting
4
Trial Phase
80
Trial Size
22.68 23 miles
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Patients With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation Agios Pharmaceuticals, Inc. Recruiting
3
Trial Phase
392
Trial Size
22.68 23 miles
Fecal Microbial Transplantation in Patients With Crohn's Disease Stony Brook University Recruiting
1
Trial Phase
40
Trial Size
22.68 23 miles
Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma Exact Sciences Corporation Recruiting N/A
1500
Trial Size
22.68 23 miles
CD4CAR for CD4+ Leukemia and Lymphoma Stony Brook University Recruiting
1
Trial Phase
20
Trial Size
22.68 23 miles
EKG Criteria and Identification of Acute Coronary Occlusion Stony Brook University Recruiting N/A
2000
Trial Size
22.68 23 miles
BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence Allergan Recruiting
2
Trial Phase
335
Trial Size
22.69 23 miles
REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL) Inovio Pharmaceuticals Recruiting
3
Trial Phase
198
Trial Size
22.87 23 miles
Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids ObsEva SA Recruiting
3
Trial Phase
500
Trial Size
23.10 23 miles
A Dose Escalation and Cohort Expansion Study of CD122-Biased Cytokine (NKTR-214) in Combination With Anti-PD-1 Antibody (Nivolumab) in Patients With Select Advanced or Metastatic Solid Tumors Nektar Therapeutics Recruiting
1
Trial Phase
250
Trial Size
23.14 23 miles
Pembrolizumab in Treating Patients With Triple-Negative Breast Cancer National Cancer Institute (NCI) Recruiting
3
Trial Phase
1000
Trial Size
23.33 23 miles
Ivabradine for Rate Control in Permanent Atrial Fibrillation Yale University Recruiting
1
Trial Phase
15
Trial Size
23.99 24 miles
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder Allergan Recruiting
3
Trial Phase
600
Trial Size
24.21 24 miles
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder Allergan Recruiting
3
Trial Phase
500
Trial Size
24.21 24 miles
Study to Evaluate the Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery in Participants With Major Depressive Disorder (MDD) Janssen Research & Development, LLC Recruiting N/A
578
Trial Size
24.21 24 miles
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01) Allergan Recruiting
3
Trial Phase
700
Trial Size
24.21 24 miles
Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Extensive Stage Small Cell Lung Cancer (SCLC) G1 Therapeutics, Inc. Recruiting
2
Trial Phase
100
Trial Size
24.21 24 miles
A Study to Evaluate a Drug (Dasotraline) on the Safety, Effectiveness and How Well the Body Tolerates it, in Adults With Moderate to Severe Binge Eating Disorder Sunovion Recruiting
3
Trial Phase
480
Trial Size
24.21 24 miles
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Patients With Chronic Obstructive Pulmonary Disease (COPD) Teva Pharmaceutical Industries Recruiting
3
Trial Phase
400
Trial Size
25.04 25 miles
A Study of LY3298176 in Participants With Type 2 Diabetes Eli Lilly and Company Recruiting
2
Trial Phase
92
Trial Size
25.04 25 miles
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Eli Lilly and Company Recruiting
3
Trial Phase
1800
Trial Size
25.04 25 miles
Adaptive Radiotherapy for Head and Neck Cancer Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
65
Trial Size
26.08 26 miles
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
52
Trial Size
26.08 26 miles
Trial of YUMI Uterine Manipulator Memorial Sloan Kettering Cancer Center Recruiting N/A
40
Trial Size
26.08 26 miles
Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer Memorial Sloan Kettering Cancer Center Recruiting
3
Trial Phase
200
Trial Size
26.08 26 miles
The Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma Memorial Sloan Kettering Cancer Center Recruiting
1
Trial Phase
18
Trial Size
26.08 26 miles
Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes Memorial Sloan Kettering Cancer Center Recruiting N/A
200
Trial Size
26.08 26 miles
A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
31
Trial Size
26.08 26 miles
A Study to Investigate the Efficacy and Safety of Cobimetinib Plus Atezolizumab in Participants With Solid Tumors Hoffmann-La Roche Recruiting
2
Trial Phase
120
Trial Size
26.08 26 miles
The Purpose of This Study is to Test Any Good and Bad Effects of a Study Drug Called Abemaciclib (LY2835219) in Patients With Recurrent Brain Tumors. Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
78
Trial Size
26.08 26 miles
Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
64
Trial Size
26.08 26 miles
A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
41
Trial Size
26.08 26 miles
Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
37
Trial Size
26.08 26 miles
Major Radiation Reduction for HPV+ Oropharyngeal Carcinoma Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
76
Trial Size
26.08 26 miles
Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Head and Neck Cancer Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
132
Trial Size
26.08 26 miles
Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
57
Trial Size
26.08 26 miles
Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
80
Trial Size
26.08 26 miles
Acupuncture for Symptoms of Nerve Damage Memorial Sloan Kettering Cancer Center Recruiting N/A
75
Trial Size
26.08 26 miles
A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis Sunovion Recruiting
2
Trial Phase
36
Trial Size
26.08 26 miles
Mobile Health Device Study for Myeloma Patients Memorial Sloan Kettering Cancer Center Recruiting N/A
40
Trial Size
26.08 26 miles
Proton Re-Irradiation for Recurrent Head and Neck Cancer Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
88
Trial Size
26.08 26 miles
Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer Memorial Sloan Kettering Cancer Center Recruiting
1
Trial Phase
12
Trial Size
26.08 26 miles
Study to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´s Subject Symptoms Management UCB Pharma Recruiting
4
Trial Phase
40
Trial Size
26.08 26 miles
A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604) Merck Sharp & Dohme Corp. Recruiting
3
Trial Phase
430
Trial Size
26.08 26 miles
Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant Memorial Sloan Kettering Cancer Center Recruiting
3
Trial Phase
202
Trial Size
26.08 26 miles
A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
25
Trial Size
26.08 26 miles
Comparison of MRI and CEDM to Evaluate Treatment Response Before Surgery Memorial Sloan Kettering Cancer Center Recruiting N/A
125
Trial Size
26.08 26 miles
A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib Memorial Sloan Kettering Cancer Center Recruiting
1
Trial Phase
30
Trial Size
26.08 26 miles
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer Memorial Sloan Kettering Cancer Center Recruiting N/A
100
Trial Size
26.08 26 miles
Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma Memorial Sloan Kettering Cancer Center Recruiting
1
Trial Phase
42
Trial Size
26.08 26 miles
Long-Term Quality of Life in Patients With Metastatic Melanoma Treated With Checkpoint Inhibitors Memorial Sloan Kettering Cancer Center Recruiting N/A
100
Trial Size
26.08 26 miles
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control Memorial Sloan Kettering Cancer Center Recruiting
3
Trial Phase
140
Trial Size
26.08 26 miles
Responses to Genetic Risk Modifier Testing Among Women With BRCA1/2 Mutations Memorial Sloan Kettering Cancer Center Recruiting N/A
195
Trial Size
26.08 26 miles
Easing Psychosocial Burden for Informal Caregivers Memorial Sloan Kettering Cancer Center Recruiting
1
Trial Phase
70
Trial Size
26.08 26 miles
Study of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal Metastases Memorial Sloan Kettering Cancer Center Recruiting
1
Trial Phase
26
Trial Size
26.08 26 miles
Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma Memorial Sloan Kettering Cancer Center Recruiting
1
Trial Phase
16
Trial Size
26.08 26 miles
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job Memorial Sloan Kettering Cancer Center Recruiting N/A
450
Trial Size
26.08 26 miles
Ixazomib Maintenance Study in Patients With AL Amyloidosis Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
47
Trial Size
26.08 26 miles
Evaluating Cancer Response to Treatment With Abemaciclib and Fulvestrant in Women With Recurrent Endometrial Cancer Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
25
Trial Size
26.08 26 miles
A Quality of Life Study in Patients Undergoing Percutaneous Biliary Drainage Memorial Sloan Kettering Cancer Center Recruiting N/A
125
Trial Size
26.08 26 miles
A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
60
Trial Size
26.08 26 miles
A Study of Dacomitinib in Patients With Metastatic EGFR Mutant Lung Cancer Previously Treated With Osimertinib Memorial Sloan Kettering Cancer Center Recruiting
1
Trial Phase
24
Trial Size
26.08 26 miles
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
142
Trial Size
26.08 26 miles
Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Cancers of the Breast and Lung Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
160
Trial Size
26.08 26 miles
A Study of Copanlisib and Ibrutinib in Mantle Cell Lymphoma Memorial Sloan Kettering Cancer Center Recruiting
1
Trial Phase
45
Trial Size
26.08 26 miles
Healthy Marriage and Responsible Fatherhood Grant Program With Phoenix House of New York Phoenix House Foundation, Inc. Recruiting N/A
3825
Trial Size
27.83 28 miles
SCP® Observational Study of the Knee Zimmer Biomet Recruiting N/A
1000
Trial Size
28.29 28 miles
A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Vascularized Lymph Node Transfer Versus Non-Surgical Management Memorial Sloan Kettering Cancer Center Recruiting N/A
150
Trial Size
28.56 29 miles
A Study to Determine if Mesh Placement During Bladder Surgery Can Reduce the Chances of Developing a Hernia Memorial Sloan Kettering Cancer Center Recruiting
3
Trial Phase
160
Trial Size
28.56 29 miles
A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
34
Trial Size
28.56 29 miles
A Study to Assess Thymic Function Using PET/CT and MRI Memorial Sloan Kettering Cancer Center Recruiting N/A
30
Trial Size
28.56 29 miles
Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
29
Trial Size
28.56 29 miles
A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
42
Trial Size
28.56 29 miles
Yoga for Symptoms of Nerve Damage Caused by Chemotherapy Memorial Sloan Kettering Cancer Center Recruiting N/A
40
Trial Size
28.56 29 miles
Treating Patients With Melanoma and ALK Alterations With Ensartinib Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
18
Trial Size
28.56 29 miles
A Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Cheek Augmentation Using Cannula Allergan Recruiting
4
Trial Phase
75
Trial Size
28.56 29 miles
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas Memorial Sloan Kettering Cancer Center Recruiting N/A
150
Trial Size
28.56 29 miles
A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy Memorial Sloan Kettering Cancer Center Recruiting
2
Trial Phase
45
Trial Size
28.56 29 miles
QP ExCELs: MultiPole Pacing (MPP) Sub-Study Biotronik, Inc. Recruiting N/A
100
Trial Size
28.73 29 miles
Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis Proteostasis Therapeutics, Inc. Recruiting
1
Trial Phase
120
Trial Size
28.73 29 miles
Virtual Reality and Active Video Games to Improve Balance in Children With Brain Injury Blythedale Children's Hospital Recruiting N/A
10
Trial Size
28.73 29 miles
Study Assessing PTI-428 Safety, Tolerability, Pharmacokinetics and Effect in Subjects With Cystic Fibrosis Proteostasis Therapeutics, Inc. Recruiting
2
Trial Phase
40
Trial Size
28.73 29 miles
Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome New York Medical College Recruiting
2
Trial Phase
20
Trial Size
28.73 29 miles
Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008 Pfizer Available N/A
0
Trial Size
29.42 29 miles
A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission Astellas Pharma Inc Recruiting
3
Trial Phase
354
Trial Size
29.42 29 miles
Efficacy and Safety Trial of Apatinib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Patients With Gastric Cancer LSK BioPartners Inc. Recruiting
3
Trial Phase
459
Trial Size
29.42 29 miles
Cardiovagal Baroreflex Deficits Impair Neurovascular Coupling and Cognition in POTS New York Medical College Recruiting
1
Trial Phase
80
Trial Size
29.42 29 miles
Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide Janssen Research & Development, LLC Recruiting
2
Trial Phase
145
Trial Size
29.56 30 miles
An 18-Month Psychotherapy of Borderline Personality Disorder Weill Medical College of Cornell University Recruiting N/A
70
Trial Size
29.57 30 miles
tDCS and Robotic Training in Adults With Cerebral Palsy Burke Medical Research Institute Recruiting N/A
22
Trial Size
29.57 30 miles
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury Avanir Pharmaceuticals Recruiting
2
Trial Phase
150
Trial Size
29.57 30 miles
Non-Invasive Stimulation for Improving Motor Function Burke Medical Research Institute Recruiting
2
Trial Phase
30
Trial Size
29.57 30 miles
Can Cognitive Training Decrease Reactive Aggression? Weill Medical College of Cornell University Recruiting N/A
90
Trial Size
29.57 30 miles
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy National Cancer Institute (NCI) Recruiting
3
Trial Phase
766
Trial Size
29.66 30 miles
Ledipasvir/Sofosbuvir in Adults With Chronic HCV Infection Who Are on Dialysis for End Stage Renal Disease Gilead Sciences Recruiting
2
Trial Phase
100
Trial Size
29.66 30 miles
Maintenance Chemotherapy With or Without Stereotactic Body Radiation Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer NRG Oncology Recruiting
2
Trial Phase
300
Trial Size
29.66 30 miles
A Study to Compare Treatment After Surgery of Abemaciclib (LY2835219) Combined With Standard Endocrine Therapy Versus Endocrine Therapy Alone in Participants With Breast Cancer Eli Lilly and Company Recruiting
3
Trial Phase
3580
Trial Size
29.66 30 miles
A Trial of BXCL701 and Pembrolizumab in Patients With Small Cell Neuroendocrine Prostate Cancer BioXcel Therapeutics Inc Recruiting
1
Trial Phase
40
Trial Size
29.66 30 miles
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study Astellas Pharma Inc Recruiting
2
Trial Phase
470
Trial Size
29.70 30 miles
Sleep Health Literacy in Head Start Albert Einstein College of Medicine, Inc. Recruiting N/A
540
Trial Size
29.72 30 miles
A clinical research study for children and adolescents with Tourette syndrome Neurocrine Biosciences Recruiting
2
Trial Phase
120
Trial Size
29.86 30 miles
To Evaluate the Safety and Efficacy of the Saline-coupled Bipolar Sealer in Primary Unilateral Total Knee Arthroplasty Northwell Health Recruiting N/A
168
Trial Size
30.72 31 miles
A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD) Massachusetts General Hospital Recruiting
4
Trial Phase
50
Trial Size
30.95 31 miles
Veliparib and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer National Cancer Institute (NCI) Recruiting
2
Trial Phase
174
Trial Size
31.25 31 miles
A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) ImmusanT, Inc. Recruiting
2
Trial Phase
146
Trial Size
31.95 32 miles
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®) Actelion Recruiting
3
Trial Phase
600
Trial Size
32.24 32 miles
A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer Myovant Sciences GmbH Recruiting
3
Trial Phase
1125
Trial Size
32.24 32 miles
Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary Incontinence Allergan Recruiting
4
Trial Phase
240
Trial Size
32.24 32 miles
Post Market Clinical Follow Up Study for ReliaTack™ Articulating Reloadable Fixation Device With Deep Purchase Tacks Medtronic - MITG Recruiting N/A
116
Trial Size
32.86 33 miles
Trial to Assess Safety and Efficacy of Lenvatinib in Combination With Everolimus in Participants With Renal Cell Carcinoma Eisai Inc. Recruiting
2
Trial Phase
306
Trial Size
33.22 33 miles
A Study of Nivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Patients With Advanced Stage Classical Hodgkin Lymphoma, Who Are Relapsed/ Refractory or Who Are Not Eligible for Autologous Stem Cell Transplant, Bristol-Myers Squibb Recruiting
3
Trial Phase
340
Trial Size
33.22 33 miles
Osteopathic Manual Treatment Parkinson's Disease and Truncal Dystonia New York Institute of Technology Recruiting N/A
30
Trial Size
34.89 35 miles
Assessing the Efficacy of Smartphone Calorie Calculator Application on Body Composition With and Without Intervention New York Institute of Technology Recruiting N/A
20
Trial Size
34.89 35 miles
Impact of Individual Cognitive Remediation for Parkinson's Disease New York Institute of Technology Recruiting N/A
20
Trial Size
34.89 35 miles
Lifestyle Intervention Program in Overweight Medical Students New York Institute of Technology Recruiting N/A
40
Trial Size
34.89 35 miles
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles Agendia Recruiting N/A
2000
Trial Size
34.95 35 miles
The TIME-2b Study: A Study of AKB-9778, a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR) Aerpio Therapeutics Recruiting
2
Trial Phase
150
Trial Size
35.52 36 miles
Orthosensor vs Conventional Total Knee Arthroplasty Columbia University Recruiting N/A
130
Trial Size
35.76 36 miles
Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease Janssen Research & Development, LLC Recruiting
2
Trial Phase
450
Trial Size
35.84 36 miles
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis Pfizer Recruiting
2
Trial Phase
360
Trial Size
35.84 36 miles
Study of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Type I or II Achalasia Ironwood Pharmaceuticals, Inc. Recruiting
2
Trial Phase
20
Trial Size
35.84 36 miles
Obalon Post-Approval Study Obalon Therapeutics, Inc. Recruiting N/A
200
Trial Size
36.15 36 miles
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355) Merck Sharp & Dohme Corp. Recruiting
3
Trial Phase
858
Trial Size
36.35 36 miles
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522) Merck Sharp & Dohme Corp. Recruiting
3
Trial Phase
855
Trial Size
36.35 36 miles
Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer Novartis Recruiting
3
Trial Phase
2000
Trial Size
36.35 36 miles
AR-Power Patient Powered Research Network Global Healthy Living Foundation Recruiting N/A
9867
Trial Size
36.35 36 miles
A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC Target PharmaSolutions, Inc. Recruiting N/A
5000
Trial Size
36.81 37 miles
Switching to a Fixed Dose Combination of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in HIV-1 Infected Adults Who Are Virologically Suppressed Gilead Sciences Recruiting
3
Trial Phase
520
Trial Size
36.81 37 miles
Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects University of Florida Recruiting
3
Trial Phase
225
Trial Size
36.81 37 miles
The Life STORRIED Study University of Pennsylvania Recruiting N/A
1100
Trial Size
36.81 37 miles
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH) Target PharmaSolutions, Inc. Recruiting N/A
15000
Trial Size
36.81 37 miles
A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis Target PharmaSolutions, Inc. Recruiting N/A
1500
Trial Size
36.81 37 miles
Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC) CymaBay Therapeutics, Inc. Recruiting
2
Trial Phase
116
Trial Size
36.81 37 miles
Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid Genfit Recruiting
2
Trial Phase
45
Trial Size
36.81 37 miles
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) Boehringer Ingelheim Recruiting
3
Trial Phase
4126
Trial Size
36.81 37 miles
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) Boehringer Ingelheim Recruiting
3
Trial Phase
2850
Trial Size
36.81 37 miles
Study to Assess Safety and Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid. Genkyotex SA Recruiting
2
Trial Phase
102
Trial Size
36.81 37 miles
Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH Boehringer Ingelheim Recruiting
2
Trial Phase
147
Trial Size
36.81 37 miles
Prospective Evaluation of Residual Bile Duct Stone by Peroral Cholangioscopy After Conventional ERCP Northwell Health Recruiting N/A
140
Trial Size
36.81 37 miles
Transcutaneous Vagus Nerve Stimulation (tVNS) and Robotic Training to Improve Arm Function After Stroke Northwell Health Recruiting
2
Trial Phase
35
Trial Size
36.81 37 miles
Restoring Motor and Sensory Hand Function in Tetraplegia Using a Neural Bypass System Northwell Health Recruiting N/A
3
Trial Size
36.81 37 miles
PoNS Clinical Experience Program (TBI) Neurohabilitation Corporation Recruiting N/A
20
Trial Size
36.81 37 miles
The Use of Trifluoperazine in Transfusion Dependent DBA Northwell Health Recruiting
1
Trial Phase
24
Trial Size
36.81 37 miles
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period Sanofi Recruiting
3
Trial Phase
500
Trial Size
36.96 37 miles
: A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men ( TRAVERSE ) AbbVie Recruiting
4
Trial Phase
6000
Trial Size
36.96 37 miles
Edwards Cardioband System ACTIVE Pivotal Clinical Trial (ACTIVE) Edwards Lifesciences Recruiting N/A
375
Trial Size
37.21 37 miles
Review of the Safety and Effectiveness of the THERMOCOOL SMARTTOUCH® SF Catheter Evaluated for Treating Symptomatic PersistenT AF (PRECEPT) Biosense Webster, Inc. Recruiting
3
Trial Phase
367
Trial Size
37.21 37 miles
Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial Cardiovascular Systems Inc Recruiting N/A
2000
Trial Size
37.21 37 miles
RESOLUTE ONYX Post-Approval Study Medtronic Vascular Recruiting N/A
510
Trial Size
37.21 37 miles
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC) Bristol-Myers Squibb Recruiting
3
Trial Phase
642
Trial Size
37.23 37 miles
Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer United Therapeutics Recruiting
2
Trial Phase
470
Trial Size
37.23 37 miles
An Open-Label, Randomized Study Comparing INCB050465 to Idelalisib in Relapsed or Refractory Follicular Lymphoma (CITADEL-203) Incyte Corporation Recruiting
2
Trial Phase
180
Trial Size
37.23 37 miles
A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC Bristol-Myers Squibb Recruiting
3
Trial Phase
420
Trial Size
37.23 37 miles
Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Normal Renal Function Kowa Research Institute, Inc. Recruiting
3
Trial Phase
630
Trial Size
37.52 38 miles
Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine Allergan Recruiting
3
Trial Phase
1650
Trial Size
37.86 38 miles
A Gene Transfer Study for Hemophilia A Spark Therapeutics Recruiting
1
Trial Phase
30
Trial Size
37.86 38 miles
Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC Novartis Recruiting
3
Trial Phase
3775
Trial Size
38.17 38 miles
Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer National Cancer Institute (NCI) Recruiting
3
Trial Phase
739
Trial Size
38.17 38 miles
A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures Sunovion Recruiting
4
Trial Phase
190
Trial Size
38.36 38 miles
Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children Opko Biologics Recruiting
3
Trial Phase
220
Trial Size
38.36 38 miles
Investigating and Characterizing the Immune Response to Prostate Cancer Winthrop University Hospital Recruiting N/A
40
Trial Size
38.36 38 miles
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors National Cancer Institute (NCI) Recruiting
2
Trial Phase
110
Trial Size
38.36 38 miles
The ReNEW Study: Maestro® New Enrollment Post-Approval Study Protocol EnteroMedics Recruiting N/A
200
Trial Size
38.36 38 miles
Phase 2 Study of an Immunotherapeutic Treatment, DPX-Survivac in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors ImmunoVaccine Technologies, Inc. (IMV Inc.) Recruiting
2
Trial Phase
232
Trial Size
38.36 38 miles
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Allergan Recruiting
3
Trial Phase
600
Trial Size
38.40 38 miles
A Safety and Efficacy Comparison of BLI4700 Bowel Prep Versus an FDA-approved Comparator in Adults Prior to Colonoscopy Braintree Laboratories Recruiting
3
Trial Phase
575
Trial Size
38.40 38 miles
Saline-Controlled Study of nSTRIDE APS for Knee Osteoarthritis Zimmer Biomet Recruiting N/A
246
Trial Size
38.72 39 miles
Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus Lupus Research Alliance Recruiting N/A
80
Trial Size
38.72 39 miles
KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial) Keryx Biopharmaceuticals Recruiting
4
Trial Phase
200
Trial Size
38.72 39 miles
A Study to Monitor the Use of an Amino Acid-Based Infant Formula Nestlé Recruiting N/A
20
Trial Size
38.72 39 miles
Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID) CSL Behring Recruiting
4
Trial Phase
51
Trial Size
38.72 39 miles
Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children Aimmune Therapeutics, Inc. Recruiting
3
Trial Phase
500
Trial Size
38.72 39 miles
A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome Bristol-Myers Squibb Recruiting
3
Trial Phase
172
Trial Size
38.72 39 miles
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) Genentech, Inc. Recruiting
1
Trial Phase
44
Trial Size
38.72 39 miles
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC) Genentech, Inc. Recruiting
2
Trial Phase
270
Trial Size
38.72 39 miles
Effect of Nusinersen on Adults With Spinal Muscular Atrophy Northwell Health Recruiting N/A
40
Trial Size
38.72 39 miles
Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE) Biogen Recruiting
2
Trial Phase
320
Trial Size
38.79 39 miles
A Study to Investigate the Efficacy and Safety of RO5285119 in Participants With Autism Spectrum Disorder (ASD) Hoffmann-La Roche Recruiting
2
Trial Phase
300
Trial Size
38.97 39 miles
Control of Myopia Using Novel Spectacle Lens Designs SightGlass Vision, Inc. Recruiting N/A
255
Trial Size
39.21 39 miles
Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer Tyme, Inc Recruiting
1
Trial Phase
42
Trial Size
39.32 39 miles
Music Therapy During Pediatric Extubation Readiness Trials Northwell Health Recruiting N/A
140
Trial Size
39.42 39 miles
Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) Medical College of Wisconsin Recruiting
2
Trial Phase
60
Trial Size
39.42 39 miles
Serratus Plane Block for Postoperative Pain Control Northwell Health Recruiting
4
Trial Phase
90
Trial Size
39.42 39 miles
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff Crestovo LLC Recruiting
2
Trial Phase
240
Trial Size
39.42 39 miles
Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis Corbus Pharmaceuticals Inc. Recruiting
2
Trial Phase
415
Trial Size
39.42 39 miles
Quality of Life in Patients With Congenital Afibrinogenemia University Hospital, Geneva Recruiting N/A
150
Trial Size
39.42 39 miles
Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease ACADIA Pharmaceuticals Inc. Recruiting
3
Trial Phase
300
Trial Size
39.42 39 miles
Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate Pfizer Available
3
Trial Phase
0
Trial Size
39.43 39 miles
Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers Rhythm Pharmaceuticals, Inc. Recruiting N/A
5000
Trial Size
39.43 39 miles
A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma Boston Biomedical, Inc Recruiting
3
Trial Phase
1132
Trial Size
39.43 39 miles
A RANDOMIZED PHASE 3 TRIAL OF TRC105 AND PAZOPANIB VERSUS PAZOPANIB ALONE IN PATIENTS WITH ADVANCED ANGIOSARCOMA Tracon Pharmaceuticals Inc. Recruiting
3
Trial Phase
124
Trial Size
39.43 39 miles
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib. Pharmacyclics Switzerland GmbH Recruiting
4
Trial Phase
500
Trial Size
39.43 39 miles
A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs AbbVie Recruiting
3
Trial Phase
550
Trial Size
39.43 39 miles
A Randomized Multicenter Study for Isolated Skin Vasculitis University of Pennsylvania Recruiting
2
Trial Phase
90
Trial Size
39.43 39 miles
A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma Acerta Pharma BV Recruiting
3
Trial Phase
546
Trial Size
39.43 39 miles
Study Evaluating Safety and Efficacy of INCB050465 Combined With Bendamustine and Obinutuzumab in Relapsed or Refractory Follicular Lymphoma (CITADEL-102) Incyte Corporation Recruiting
1
Trial Phase
45
Trial Size
39.43 39 miles
A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204) Incyte Corporation Recruiting
2
Trial Phase
120
Trial Size
39.43 39 miles
Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter's Transformation or Richter's Syndrome Patients Northwell Health Recruiting
2
Trial Phase
43
Trial Size
39.43 39 miles
Vedolizumab IV in Pediatric Participants With Ulcerative Colitis or Crohn's Disease Takeda Recruiting
2
Trial Phase
80
Trial Size
39.43 39 miles
Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects Biodesix, Inc. Recruiting N/A
1000
Trial Size
39.43 39 miles
A Phase I Study Of Etrolizumab Followed By Open-Label Extension And Safety Monitoring In Pediatric Patients With Moderate To Severe Ulcerative Colitis Or Moderate To Severe Crohn's Disease Hoffmann-La Roche Recruiting
1
Trial Phase
12
Trial Size
39.43 39 miles
A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia BeiGene Recruiting
3
Trial Phase
400
Trial Size
39.43 39 miles
Study of Zanubrutinib (BGB-3111) in Patients With Marginal Zone Lymphoma BeiGene Recruiting
2
Trial Phase
65
Trial Size
39.43 39 miles
Transcutaneous VNS to Treat Pediatric IBD Northwell Health Recruiting N/A
30
Trial Size
39.43 39 miles
Impact of Hidradenitis Suppurativa on Quality of Life Functions Montefiore Medical Center Recruiting N/A
400
Trial Size
40.11 40 miles
Intraoperative Methadone Administration for Improved Pain Control in Spinal Fusion Patients Montefiore Medical Center Recruiting
4
Trial Phase
120
Trial Size
40.11 40 miles
Study to Compare Lefamulin to Moxifloxacin for the Treatment of Adults With Pneumonia Nabriva Therapeutics AG Recruiting
3
Trial Phase
738
Trial Size
40.11 40 miles
Study of Allogeneic EBV-CTLs in EBV-Associated Lymphomas and Lymphoproliferative Disorders Atara Biotherapeutics Available N/A
0
Trial Size
40.11 40 miles
Gene Transfer Clinical Study in Crigler-Najjar Syndrome Audentes Therapeutics Recruiting
1
Trial Phase
12
Trial Size
40.11 40 miles
The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study UroGen Pharma Ltd. Recruiting
3
Trial Phase
74
Trial Size
40.11 40 miles
Enhanced Recovery at Cesarean Birth to Improve Postoperative Outcomes and Reduce Postoperative Length of Stay Montefiore Medical Center Recruiting N/A
118
Trial Size
40.11 40 miles
Novel Mobile Device Application to Improve Adherence National Institute of Allergy and Infectious Diseases (NIAID) Recruiting N/A
60
Trial Size
40.11 40 miles
Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients Jazz Pharmaceuticals Recruiting
3
Trial Phase
400
Trial Size
40.11 40 miles
Topical Sodium Nitrite in Sickle Cell Disease and Leg Ulcers Montefiore Medical Center Recruiting
2
Trial Phase
50
Trial Size
40.11 40 miles
Low Dose Radiotherapy for Advanced Hidradenitis Suppurativa Montefiore Medical Center Recruiting N/A
20
Trial Size
40.11 40 miles
A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH) Actelion Recruiting
3
Trial Phase
300
Trial Size
40.11 40 miles
L-citrulline for Prevention of Sequelae of Acute Lung Injury in Pediatrics Undergoing Cardiopulmonary Bypass for Heart Defects Asklepion Pharmaceuticals, LLC Recruiting
3
Trial Phase
190
Trial Size
40.11 40 miles
Educational Videos to Address Racial Disparities in Implantable Cardioverter Defibrillator Therapy Via Innovative Designs Duke University Recruiting N/A
480
Trial Size
40.11 40 miles
A National Registry For Patients With Hidradenitis Suppurativa Montefiore Medical Center Recruiting N/A
400
Trial Size
40.11 40 miles
Safety of Intravenous Neridronic Acid in CRPS Gr√ľnenthal GmbH Recruiting
3
Trial Phase
220
Trial Size
40.11 40 miles
Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients Astellas Pharma Inc Recruiting
2
Trial Phase
60
Trial Size
40.11 40 miles
A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naïve Adults With Chronic Hepatitis C Virus (HCV) Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis AbbVie Recruiting
3
Trial Phase
270
Trial Size
40.11 40 miles
Study of LN-145 Autologous Tumor Infiltrating Lymphocytes in the Treatment of Squamous Cell Carcinoma of the Head & Neck Iovance Biotherapeutics, Inc. Recruiting
2
Trial Phase
47
Trial Size
40.11 40 miles
Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia Relypsa, Inc. Recruiting
2
Trial Phase
54
Trial Size
40.11 40 miles
Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272) Incyte Corporation Recruiting
2
Trial Phase
120
Trial Size
40.11 40 miles
Determination of Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day Oragenics, Inc. Recruiting
2
Trial Phase
200
Trial Size
40.11 40 miles
Safety Study of Gene Modified Donor T-cells Following TCR + Alpha Beta Depleted Stem Cell Transplant Bellicum Pharmaceuticals Recruiting
1
Trial Phase
120
Trial Size
40.11 40 miles
ATA129 for Allogeneic Hematopoietic Cell Transplant Subjects With EBV-PTLD After Failure of Rituximab Atara Biotherapeutics Recruiting
3
Trial Phase
33
Trial Size
40.11 40 miles
ATA129 for Solid Organ Transplant Subjects With EBV-PTLD After Failure of Rituximab or Rituximab and Chemotherapy Atara Biotherapeutics Recruiting
3
Trial Phase
66
Trial Size
40.11 40 miles
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Disorder Avanir Pharmaceuticals Recruiting
2
Trial Phase
150
Trial Size
40.11 40 miles
A Study of MACI in Patients Aged 10 to <17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee Vericel Corporation Recruiting
3
Trial Phase
45
Trial Size
40.11 40 miles
Phase I Study of Fractionated Stereotactic Radiation Therapy Albert Einstein College of Medicine, Inc. Recruiting
1
Trial Phase
43
Trial Size
40.11 40 miles
Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment Columbia University Recruiting N/A
30
Trial Size
40.11 40 miles
Adapting and Expanding the Asthma-Educator App Montefiore Medical Center Recruiting N/A
130
Trial Size
40.11 40 miles
Phase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLC Mirati Therapeutics Inc. Recruiting
1
Trial Phase
119
Trial Size
40.13 40 miles
Randomized Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism Daiichi Sankyo, Inc. Recruiting
1
Trial Phase
132
Trial Size
40.13 40 miles
Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer Eastern Cooperative Oncology Group Recruiting
3
Trial Phase
164946
Trial Size
40.13 40 miles
Expanded Access Protocol for Therapeutic Use of 177Lu-DOTA0-Tyr3-Octreotate in Midgut Carcinoid Tumors Advanced Accelerator Applications Available N/A
0
Trial Size
40.13 40 miles
Compassionate Use of SOM230 for Hyperinsulinemic/Hypoglycemia Montefiore Medical Center Available N/A
0
Trial Size
40.13 40 miles
Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery National Cancer Institute (NCI) Recruiting
2
Trial Phase
40
Trial Size
40.13 40 miles
Study to Evaluate the Safety of Griffithsin in a Carrageenan Gel in Healthy Women Population Council Recruiting
1
Trial Phase
36
Trial Size
40.13 40 miles
Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC) Novartis Recruiting
2
Trial Phase
110
Trial Size
40.13 40 miles
Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD) Cumberland Pharmaceuticals Recruiting
2
Trial Phase
76
Trial Size
40.13 40 miles
Trametinib in Treating Patients With Epithelioid Hemangioendothelioma That Is Metastatic, Locally Advanced, or Cannot Be Removed by Surgery National Cancer Institute (NCI) Recruiting
2
Trial Phase
27
Trial Size
40.13 40 miles
Study of Pembrolizumab (MK-3475) in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(MK-3475-199/KEYNOTE-199) Merck Sharp & Dohme Corp. Recruiting
2
Trial Phase
370
Trial Size
40.13 40 miles
A Study to Evaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Cancer Bristol-Myers Squibb Recruiting
4
Trial Phase
200
Trial Size
40.13 40 miles
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564) Merck Sharp & Dohme Corp. Recruiting
3
Trial Phase
950
Trial Size
40.13 40 miles
Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Subjects With Locally Advanced or Metastatic Solid Tumors BeiGene Recruiting
1
Trial Phase
150
Trial Size
40.13 40 miles
A Trial to Evaluate the Efficacy and Safety of Two Concentrations of VBP-926 Solution for the Treatment of Chemotherapy-associated Paronychia in Cancer Patients Veloce BioPharma LLC Recruiting
2
Trial Phase
150
Trial Size
40.13 40 miles
Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery Avelas Biosciences, Inc. Recruiting
2
Trial Phase
110
Trial Size
40.13 40 miles
A Study to Evaluate Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) Hoffmann-La Roche Recruiting
2
Trial Phase
580
Trial Size
40.13 40 miles
VGX-3100 Followed by Electroporation Alone or in Combination With Imiquimod for the Treatment of Human Papilloma Virus HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Vulva Inovio Pharmaceuticals Recruiting
2
Trial Phase
36
Trial Size
40.13 40 miles
PERL Continuous Glucose Monitoring (CGM) Study Joslin Diabetes Center Recruiting N/A
300
Trial Size
40.13 40 miles
Effect of Angulus on Patient-elevation Compliance Angulus, LLC Recruiting N/A
200
Trial Size
40.13 40 miles
Regulation of Endogenous Glucose Production by Central KATP Channels Albert Einstein College of Medicine, Inc. Recruiting
2
Trial Phase
45
Trial Size
40.13 40 miles
Evaluation of Regulation Focused Psychotherapy for Children Yeshiva University Recruiting N/A
40
Trial Size
40.13 40 miles
Program Refinements to Optimize Model Impact and Scalability Based on Evidence City University of New York, School of Public Health Recruiting N/A
594
Trial Size
40.13 40 miles
Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer Albert Einstein College of Medicine Recruiting
2
Trial Phase
25
Trial Size
40.13 40 miles
Effectiveness of the Husky Reads Program to Increase Fruit and Vegetable Preference and Food Group Identification in Preschool Children UConn Health Recruiting N/A
900
Trial Size
40.20 40 miles
Precision Pain Self-Management in Young Adults With Irritable Bowel Syndrome University of Connecticut Recruiting N/A
80
Trial Size
40.20 40 miles
AMPLEX Ankle Fusion Ferring Pharmaceuticals Recruiting N/A
480
Trial Size
40.20 40 miles
Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines The Jackson Laboratory Recruiting N/A
40
Trial Size
40.20 40 miles
A Psychotherapy Development Study for Internet Gaming UConn Health Recruiting N/A
60
Trial Size
40.20 40 miles
A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp Celgene Recruiting
3
Trial Phase
300
Trial Size
40.20 40 miles
Water Immersion and Polyp Detection: A Randomized Controlled Trial Dartmouth-Hitchcock Medical Center Recruiting N/A
124
Trial Size
40.20 40 miles
Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD Multidisciplinary Association for Psychedelic Studies Recruiting
2
Trial Phase
60
Trial Size
40.20 40 miles
ATHN 8: PUPs Matter Study American Thrombosis and Hemostasis Network Recruiting N/A
250
Trial Size
40.20 40 miles
Vaccination Efficacy With Metformin in Older Adults UConn Health Recruiting
1
Trial Phase
40
Trial Size
40.20 40 miles
A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps. Flex Pharma, Inc. Recruiting
2
Trial Phase
120
Trial Size
40.22 40 miles
A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS) Cytokinetics Recruiting
2
Trial Phase
445
Trial Size
40.22 40 miles
HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors Nationwide Children's Hospital Recruiting
4
Trial Phase
250
Trial Size
40.25 40 miles
A Study of the Relationship of Psychosocial Function With Mood Symptoms in Offspring of Parents With Bipolar Disorder Janssen Research & Development, LLC Recruiting N/A
208
Trial Size
40.53 41 miles
Boost rTMS for Auditory Verbal Hallucinations Northwell Health Recruiting N/A
40
Trial Size
40.53 41 miles
A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) Takeda Recruiting
2
Trial Phase
38
Trial Size
40.56 41 miles
Study of ONO-7579 in Patients With Advanced Solid Tumors/ NTRK Gene Fusion Positive Advanced Solid Tumors Ono Pharmaceutical Co. Ltd Recruiting
1
Trial Phase
65
Trial Size
40.56 41 miles
Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD Tonix Pharmaceuticals, Inc. Recruiting
3
Trial Phase
550
Trial Size
40.71 41 miles
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease Gilead Sciences Recruiting
3
Trial Phase
1320
Trial Size
41.22 41 miles
Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis Vulgaris Sienna Labs Recruiting
2
Trial Phase
192
Trial Size
41.22 41 miles
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis Gilead Sciences Recruiting
3
Trial Phase
1300
Trial Size
41.22 41 miles
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis Gilead Sciences Recruiting
3
Trial Phase
1000
Trial Size
41.22 41 miles
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease Gilead Sciences Recruiting
3
Trial Phase
1000
Trial Size
41.22 41 miles
Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2) Ferring Pharmaceuticals Recruiting
3
Trial Phase
550
Trial Size
41.22 41 miles
Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1) Ferring Pharmaceuticals Recruiting
3
Trial Phase
550
Trial Size
41.22 41 miles
A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance Astellas Pharma Inc Recruiting
2
Trial Phase
222
Trial Size
41.35 41 miles
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer Altor BioScience Recruiting
2
Trial Phase
100
Trial Size
41.35 41 miles
Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract Mati Therapeutics Inc. Recruiting
2
Trial Phase
75
Trial Size
41.35 41 miles
Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) Urovant Sciences GmbH Recruiting
3
Trial Phase
1088
Trial Size
41.35 41 miles
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin Menlo Therapeutics Inc. Recruiting
2
Trial Phase
200
Trial Size
41.35 41 miles
A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia Gemphire Therapeutics, Inc. Recruiting
2
Trial Phase
104
Trial Size
41.57 42 miles
CTCL Directed Therapy James J. Peters Veterans Affairs Medical Center Recruiting
1
Trial Phase
8
Trial Size
41.57 42 miles
Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals With Spinal Cord Injury James J. Peters Veterans Affairs Medical Center Recruiting
4
Trial Phase
65
Trial Size
41.57 42 miles

View Legend


Listings display only those clinical trials that have locations in the USA. Distances calculated are an approximation only.

ClinicalTrialsLocator.com provides clinical trial listings in an easy to view format. All clinical trial information is pulled directly from ClinicalTrials.gov. This website does not guarantee acceptance into any clinical trial, and is not responsible for adverse events that may be incurred from a clinical trial.